Timo Schomann
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Correction: Preclinical evaluation of glycan-targeting monoclonal antibodies for bimodal near-infrared fluorescence and photoacoustic imaging of gastrointestinal cancers.
Journal: EJNMMI research
Published: September 02, 2025
Poloxamer-based thermosensitive injectable hydrogels containing a self-assembling peptide for In situ gelation.
Journal: Computational and structural biotechnology journal
Published: July 21, 2025
Preclinical evaluation of glycan-targeting monoclonal antibodies for bimodal near-infrared fluorescence and photoacoustic imaging of gastrointestinal cancers.
Journal: EJNMMI research
Published: March 27, 2025
Correction: Yu et al. Achieving Effective Multimodal Imaging with Rare-Earth Ion-Doped CaF2 Nanoparticles. Pharmaceutics 2022, 14, 840.
Journal: Pharmaceutics
Published: October 13, 2023
Correction: Yu et al. Rare-Earth-Metal (Nd3+, Ce3+ and Gd3+)-Doped CaF2: Nanoparticles for Multimodal Imaging in Biomedical Applications. Pharmaceutics 2022, 14, 2796.
Journal: Pharmaceutics
Published: October 13, 2023
Inhibition of murine colorectal cancer metastasis by targeting M2-TAM through STAT3/NF-kB/AKT signaling using macrophage 1-derived extracellular vesicles loaded with oxaliplatin, retinoic acid, and Libidibia ferrea.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 30, 2023
Dual-Targeting Nanoliposome Improves Proinflammatory Immunomodulation of the Tumor Microenvironment.
Dual-Targeting Nanoliposome Improves Proinflammatory Immunomodulation of the Tumor Microenvironment.
Journal: Advanced healthcare materials
Published: June 29, 2023
Preclinical evaluation of EpCAM-binding designed ankyrin repeat proteins (DARPins) as targeting moieties for bimodal near-infrared fluorescence and photoacoustic imaging of cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 27, 2023
Enhancing anti-tumor immunity through liposomal oxaliplatin and localized immunotherapy via STING activation.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: March 09, 2023
Erythrocyte-cancer hybrid membrane-coated reduction-sensitive nanoparticles for enhancing chemotherapy efficacy in breast cancer.
Journal: Biomaterials advances
Published: December 07, 2022
Effective combination of liposome-targeted chemotherapy and PD-L1 blockade of murine colon cancer.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: September 28, 2022
Last Updated: 09/26/2026